This presentation discusses the use of psychotropic medications in IDD. Topics covered include a background on the use of psychotropic medications, current prevalence of use, research on use and adverse effects, and expected outcomes.
This activity is approved for 1.50 contact hours.
2015 NADD Conference session recording.
Disclosure: Joseph L. Calles, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.